New York State Common Retirement Fund
FDMT icon

New York State Common Retirement Fund’s 4D Molecular Therapeutics FDMT Stock Holding History

New York State Common Retirement Fund’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$167K Hold
12,543
– – ﹤0.01% 2442
2026
Q1 		$117K Hold
12,543
– – ﹤0.01% 2455
2025
Q4 		$94.1K Hold
12,543
– – ﹤0.01% 2628
2025
Q3 		$109K Hold
12,543
– – ﹤0.01% 2577
2025
Q2 		$46.5K Hold
12,543
– – ﹤0.01% 2959
2025
Q1 		$40.5K Hold
12,543
– – ﹤0.01% 2842
2024
Q4 		$69.9K Sell
12,543
-3,100
-20% -$24.3K ﹤0.01% 2741
2024
Q3 		$169K Sell
15,643
-5,400
-26% -$89.6K ﹤0.01% 2379
2024
Q2 		$442K Buy
21,043
+3,868
+23% +$97K ﹤0.01% 2091
2024
Q1 		$547K Sell
17,175
-2,247
-12% -$57.3K ﹤0.01% 2040
2023
Q4 		$393K Buy
19,422
+5,609
+41% +$73.8K ﹤0.01% 2189
2023
Q3 		$176K Buy
13,813
+197
+1% +$3.29K ﹤0.01% 2482
2023
Q2 		$246K Sell
13,616
-2,545
-16% -$46.9K ﹤0.01% 2402
2023
Q1 		$278K Sell
16,161
-3,473
-18% -$67.5K ﹤0.01% 2455
2022
Q4 		$436K Sell
19,634
-27
-0.1% -$417 ﹤0.01% 2379
2022
Q3 		$158K Buy
19,661
+9,956
+103% +$90.2K ﹤0.01% 2853
2022
Q2 		$68K Sell
9,705
-13,239
-58% -$129K ﹤0.01% 3188
2022
Q1 		$347K Buy
22,944
+8,570
+60% +$135K ﹤0.01% 2570
2021
Q4 		$315K Buy
14,374
+4,879
+51% +$120K ﹤0.01% 2684
2021
Q3 		$256K Buy
9,495
+1,734
+22% +$49.4K ﹤0.01% 2811
2021
Q2 		$187K Buy
7,761
+4,261
+122% +$130K ﹤0.01% 3066
2021
Q1 		$152K Buy
+3,500
New +$155K ﹤0.01% 2932

Other funds holding FDMT

JT
Jupiter Topco New York $245B AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM

New York State Common Retirement Fund's FDMT Position: Q2 2026 in Review

New York State Common Retirement Fund held its 4D Molecular Therapeutics (FDMT) position steady in Q2 2026 at 12,543 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #2442.

New York State Common Retirement Fund first reported a position in FDMT in Q1 2021 and has held it in 22 quarters since. The position peaked at $547K in Q1 2024. 157 funds tracked by Wall St. Rank hold FDMT as of Q2 2026.

  • New York State Common Retirement Fund held 12,543 shares of 4D Molecular Therapeutics worth $167K as of Q2 2026.
  • New York State Common Retirement Fund left its 4D Molecular Therapeutics share count unchanged in Q2 2026.
  • 4D Molecular Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2442 holding.
  • New York State Common Retirement Fund first reported a position in 4D Molecular Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • New York State Common Retirement Fund's 4D Molecular Therapeutics position peaked at $547K in Q1 2024.
  • 157 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.